Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10285-06-0
2. (+)-intermedine
3. Intermedina
4. Intermedinum
5. 9-(+)-trachelanthylretronecine
6. Dlc9fep81a
7. [(7r,8r)-7-hydroxy-5,6,7,8-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate
8. ((1r,7ar)-1-hydroxy-2,3,5,7a-tetrahydro-1h-pyrrolizin-7-yl)methyl (2s,3r)-2,3-dihydroxy-2-isopropylbutanoate
9. [(1r,7ar)-1-hydroxy-2,3,5,7a-tetrahydro-1h-pyrrolo[1,2-a]pyrrol-7-yl]methyl (2s,3r)-2,3-dihydroxy-2-isopropylbutanoate
10. Unii-dlc9fep81a
11. Intermedine, Hplc Grade
12. 3'-epi-lycopsamine
13. Schembl23464
14. Intermedine, (+)-
15. Chebi:5941
16. Dtxsid001020073
17. Mfcd09970420
18. Butanoic Acid, 2,3-dihydroxy-2-(1-methylethyl)-, ((1r,7ar)-2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, (2s,3r)-
19. Butanoic Acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, (1r-(1alpha,7(2s*,3r*),7abeta))-
20. Xi161638
21. Hy-113845
22. Cs-0062945
23. A902553
24. J-000818
25. Q27106936
26. (2s,3r)-2,3-dihydroxy-2-(1-methylethyl)butanoic Acid [(1r,7ar)-2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl]methyl Ester
27. Butanoic Acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1h-pyrrolizin-7-yl)methyl Ester, (1r-(1.alpha.,7(2s*,3r*),7a.beta.))-
Molecular Weight | 299.36 g/mol |
---|---|
Molecular Formula | C15H25NO5 |
XLogP3 | -0.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 299.17327290 g/mol |
Monoisotopic Mass | 299.17327290 g/mol |
Topological Polar Surface Area | 90.2 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 436 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Intermedine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Intermedine manufacturer or Intermedine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Intermedine manufacturer or Intermedine supplier.
PharmaCompass also assists you with knowing the Intermedine API Price utilized in the formulation of products. Intermedine API Price is not always fixed or binding as the Intermedine Price is obtained through a variety of data sources. The Intermedine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Intermedine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Intermedine, including repackagers and relabelers. The FDA regulates Intermedine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Intermedine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Intermedine supplier is an individual or a company that provides Intermedine active pharmaceutical ingredient (API) or Intermedine finished formulations upon request. The Intermedine suppliers may include Intermedine API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Intermedine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Intermedine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Intermedine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Intermedine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Intermedine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Intermedine suppliers with NDC on PharmaCompass.
Intermedine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Intermedine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Intermedine GMP manufacturer or Intermedine GMP API supplier for your needs.
A Intermedine CoA (Certificate of Analysis) is a formal document that attests to Intermedine's compliance with Intermedine specifications and serves as a tool for batch-level quality control.
Intermedine CoA mostly includes findings from lab analyses of a specific batch. For each Intermedine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Intermedine may be tested according to a variety of international standards, such as European Pharmacopoeia (Intermedine EP), Intermedine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Intermedine USP).